Last reviewed · How we verify

NCT07041411: TSL

Transcrestal Sinus Lift With OSSIX Bone vs BIOSS Collagen

Completed NA Last updated 27 June 2025
What this trial tests

NA trial testing maxillary sinus elevation through transcrestal approach using OSSIX® Bone in Sinus Lift in 26 participants. Completed in 22 March 2025.

Timeline
10 November 2022
Primary endpoint
2 May 2024
22 March 2025

Quick facts

Lead sponsorStudio Odontoiatrico Associato Dr. P. Cicchese e L. Canullo
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment26
Start date10 November 2022
Primary completion2 May 2024
Estimated completion22 March 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Studio Odontoiatrico Associato Dr. P. Cicchese e L. Canullo

Who can join

Adults 18 to 80, any sex, with Sinus Lift or Graft Materials. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary: Histologically analyse the quality of bone regeneration after graft material insertion in severely resorbed maxilla. Secondary: Radiological analysis of the volume of the bone regenerations with the shirnkage rate of the graft material. clinical study of 20 patients 13 in OSSIX Bone group 13 in Bio-Oss Collagen group all patients requiring a regenerative procedure (sinus lift) having less than 3mm of residual bone height (RBH) with the impossibility to place the implants at the time of regenerative proc 6 months follow up for the first endpoint. (collection of the histological sample) 12 months follow up - long term clinical evaluation. tests performed: Cone Beam Computed Tomography (CBCT), clinical evaluation, X-ray

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Studio Odontoiatrico Associato Dr. P. Cicchese e L. Canullo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07041411.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing